MYCN放大定义了IDH突变质瘤中的攻击性表型
Xujun Xie1, Qin Yan1, Fang Wang2
1Department of Pathology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
The journal of pathology. Clinical research
|August 26, 2025
概括
在IDH突变性质瘤中,MYCN放大显著恶化预后,特别是低度类型. 将MYCN状态纳入分级可以提高这些脑瘤的预后准确性.
科学领域:
- 神经瘤学
- 分子诊断
- 癌症分级系统
背景情况:
- 世卫组织的分类包括分子变化在质瘤诊断中.
- 在IDH突变性质瘤中,MYCN扩增的预后作用尚不清楚.
- 在其他癌症中,MYCN放大与不良结果有关.
研究的目的:
- 研究MYCN放大在IDH突变质瘤的预后意义.
- 评估MYCN放大对生存和瘤特征的影响.
- 提议一个完善的分类系统,包括MYCN的地位.
主要方法:
- 分析了190名IDH突变质瘤患者.
- 使用现场光混合 (FISH) 确定MYCN放大.
- 通过卡普兰-梅尔和考克斯回归评估生存率;评估瘤形态.
主要成果:
- 在14.7%的病例中发现MYCN放大,与较高的等级和Ki-67指数相关.
- MYCN放大显著降低了整体存活率,特别是在较低级别的质瘤中.
- 一个基于MYCN的建议分类系统显示出更好的预后分层.
- 在50%的MYCN增强病例中观察到表皮形态.
结论:
- 在IDH突变性质瘤中,MYCN放大是关键的预后标志物.
- 它与明显的上皮状组织学特征有关.
- 将MYCN状态纳入分级可以提高预后准确性和临床决策.
相关概念视频
Induced Pluripotent Stem Cells
4.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.4K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K


